NO128154B - - Google Patents
Download PDFInfo
- Publication number
- NO128154B NO128154B NO02886/70A NO288670A NO128154B NO 128154 B NO128154 B NO 128154B NO 02886/70 A NO02886/70 A NO 02886/70A NO 288670 A NO288670 A NO 288670A NO 128154 B NO128154 B NO 128154B
- Authority
- NO
- Norway
- Prior art keywords
- mol
- solution
- general formula
- benzodiazepine
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- GUJAGMICFDYKNR-UHFFFAOYSA-N 1,4-benzodiazepine Chemical class N1C=CN=CC2=CC=CC=C12 GUJAGMICFDYKNR-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- -1 muscle relaxing Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 5
- 239000013078 crystal Substances 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 3
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- GWEHVDNNLFDJLR-UHFFFAOYSA-N 1,3-diphenylurea Chemical compound C=1C=CC=CC=1NC(=O)NC1=CC=CC=C1 GWEHVDNNLFDJLR-UHFFFAOYSA-N 0.000 description 2
- RXYPXQSKLGGKOL-UHFFFAOYSA-N 1,4-dimethylpiperazine Chemical compound CN1CCN(C)CC1 RXYPXQSKLGGKOL-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- JERGQZXGPHHMRW-UHFFFAOYSA-N ClC=1C=CC2=C(C=[N+](CC(N2)=O)[O-])C1 Chemical compound ClC=1C=CC2=C(C=[N+](CC(N2)=O)[O-])C1 JERGQZXGPHHMRW-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- ANRQGKOBLBYXFM-UHFFFAOYSA-M phenylmagnesium bromide Chemical compound Br[Mg]C1=CC=CC=C1 ANRQGKOBLBYXFM-UHFFFAOYSA-M 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3833969 | 1969-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO128154B true NO128154B (de) | 1973-10-08 |
Family
ID=10402826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO02886/70A NO128154B (de) | 1969-07-30 | 1970-07-23 |
Country Status (8)
Country | Link |
---|---|
AU (1) | AU1806970A (de) |
BE (1) | BE754049A (de) |
DE (1) | DE2037668A1 (de) |
FR (1) | FR2059579A1 (de) |
IL (1) | IL35001A0 (de) |
NL (1) | NL7011246A (de) |
NO (1) | NO128154B (de) |
ZA (1) | ZA705076B (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU34997B (en) * | 1970-03-27 | 1980-06-30 | Hiroyuki Tawada | Process for preparing benzodiazepine derivatives |
-
1970
- 1970-07-23 ZA ZA705076A patent/ZA705076B/xx unknown
- 1970-07-23 NO NO02886/70A patent/NO128154B/no unknown
- 1970-07-27 IL IL35001A patent/IL35001A0/xx unknown
- 1970-07-27 AU AU18069/70A patent/AU1806970A/en not_active Expired
- 1970-07-28 BE BE754049D patent/BE754049A/xx unknown
- 1970-07-29 FR FR7027939A patent/FR2059579A1/fr not_active Withdrawn
- 1970-07-29 DE DE19702037668 patent/DE2037668A1/de active Pending
- 1970-07-29 NL NL7011246A patent/NL7011246A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA705076B (en) | 1971-04-28 |
FR2059579A1 (en) | 1971-06-04 |
AU1806970A (en) | 1972-02-03 |
IL35001A0 (en) | 1970-09-17 |
DE2037668A1 (de) | 1971-02-11 |
NL7011246A (de) | 1971-02-02 |
BE754049A (fr) | 1970-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3078214A (en) | Treatment of mental disturbances with esters of indoles | |
NO142865B (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive karbazoler | |
NO128154B (de) | ||
SU910118A3 (ru) | Способ получени N @ -глюкофуранозид-6-ил-N @ -нитрозомочевины | |
US3349128A (en) | Production of omicron-(monoalkyl aminoalkyl) oximes of dibenzo-[a, d] cyclohepten-5-ones | |
US4713453A (en) | Oxabicycloheptane derivatives | |
US3284503A (en) | 2-cycloalkylmethylamino-benzhydrols and benzophenones | |
US3789056A (en) | A-phenylsuccinimido-halo-sulphonamido-benzenes | |
US3028394A (en) | 9-phenyl octahydroindole compounds and process of making same | |
US4399145A (en) | Lactams Compositions and pharmaceutical methods of use | |
US3442890A (en) | Substituted 3-benzazocin-16-ones | |
GILMAN et al. | The synthesis of N-methyl-3-isopropyl-4-dimethylaminophenyl carbamate and some related derivatives | |
US3622610A (en) | Sulfonate esters of gallic acid derivatives | |
SU430552A1 (ru) | Способ получения производных бензодиазепина | |
US3396171A (en) | 2:3:4:5-tetrahydro-1:4-methano-1h-3-benzazepins | |
US3221050A (en) | 2-cycloalkylcarbonylamido-5-halobenzophenones | |
US3098853A (en) | Nu-acylated derivatives of 4-amino-2-carbocyclic-3-methylmorpholines | |
NO158505B (no) | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt 7beta-substituert malonamido-1-oksadetia 7alfa-metoksy-3-(1-metyltetrazol-5-yl)-tiometyl cefalosporin. | |
US3429884A (en) | Novel quinolizidine derivatives or salts thereof and process for preparing the same | |
US3124591A (en) | X-substituted i | |
US2696488A (en) | 2, 4, 6-tris-(1-piperidyl)-5-benzylpyrimidine and process of preparing same | |
US3439016A (en) | 2-amino-2' and 4'-cyanobenzophenones | |
NO119840B (de) | ||
Garlock Jr et al. | Studies in the Anthracene Series. I. Methyl Ketones and Carbinolamines Derived from 1, 2, 3, 4-Tetrahydroanthracene1 | |
US1906221A (en) | Hydroxy-diphenylindoles |